Duramed
As of the edition of 20 October 2026, Duramed runs 15 drugs, 2 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 2 |
| Went quiet | 13 |
| Total | 15 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Norethindrone acetate | none listed | 3 |
| Norethindrone | none listed | 3 |
A route B row is one company at one target.
Where its trials are
- Urinary and reproductive: 6 trials led
- Pregnancy and women's health: 3 trials led
- Cancer: 1 trials led